The reason why spontaneous clotting usually occurs in veins, the danger of travelling blood clots, and the reason for the clots lodging in the lungs. Introduction: Hemostasis is the process by which the body stops blood loss, and there are three major hemostatic mechanisms: spasm of blood vessels, formation of platelet plug, and clotting of blood. When an injury occurs, local blood vessels first constrict to reduce blood flow to the area; next, platelets adhere to the collagen fibers of the vessel wall exposed by the injury and release substances that further promote platelet aggregation and vasoconstriction such as serotonin, adenosine diphosphate, and thromboxane A 2 ; and subsequently, the coagulation of blood occurs. These mechanisms together help to stop blood loss. Blood coagulation itself consists of two pathways (the intrinsic and extrinsic mechanisms) that reach a common convergence point after following different steps. The common convergence point of the two pathways is reached when factor X is formed. This continues on to the end point, which is the formation of fibrin polymer molecules that form the blood clot. Disorders in blood clotting include the absence of appropriate clotting (clotting deficiency) and unwanted clotting (thrombosis).

Question

Want to see the full answer?

Answer 1

Question

Chapter 18.5, Problem 13AYLO

Summary Introduction

To discuss:

The reason why spontaneous clotting usually occurs in veins, the danger of travelling blood clots, and the reason for the clots lodging in the lungs.

Introduction:

Hemostasis is the process by which the body stops blood loss, and there are three major hemostatic mechanisms: spasm of blood vessels, formation of platelet plug, and clotting of blood. When an injury occurs, local blood vessels first constrict to reduce blood flow to the area; next, platelets adhere to the collagen fibers of the vessel wall exposed by the injury and release substances that further promote platelet aggregation and vasoconstriction such as serotonin, adenosine diphosphate, and thromboxane A₂; and subsequently, the coagulation of blood occurs. These mechanisms together help to stop blood loss.

Blood coagulation itself consists of two pathways (the intrinsic and extrinsic mechanisms) that reach a common convergence point after following different steps. The common convergence point of the two pathways is reached when factor X is formed. This continues on to the end point, which is the formation of fibrin polymer molecules that form the blood clot.

Disorders in blood clotting include the absence of appropriate clotting (clotting deficiency) and unwanted clotting (thrombosis).

Expert Solution & Answer

Want to see the full answer?

Check out a sample textbook solution

See solution

Students have asked these similar questions

According to a recent study, 1 out of 50,000 people will be diagnosed with cystic fibrosis. Cystic fibrosis can be caused by a mutant form of the CFTR gene (dominant gene symbol is F and mutant is f). A. Using the rate of incidence above, what is the frequency of carriers of the cystic fibrosis allele for CFTR in the US? (3 pts) B. In a clinical study, 400 people from the population mentioned in (A.) were genotyped for BRCA1 Listed below are the results. Are these results in Hardy- Weinberg equilibrium? Use Chi Square to show whether or not they are. (3 pts) BRCA1 genotype # of women 390 BB Bb bb 10 0 12pt Paragraph L BIUAV V T² v V

Outline a method for using apomixis to maintain feminized CannabisAssume apomixis is controlled by a single dominant gene. You can choose the type of apomixis: obligate or facultative, gametophytic or sporophytic. Discuss advantages and disadvantages of your proposed method.

Kinetics: One-Compartment First-Order Absorption 1. In vivo testing provides valuable insight into a drug’s kinetics. Assessing drug kinetics following multiple routes of administration provides greater insight than a single route of administration alone. The following data was collected in 250-g rats following bolus IV, oral (PO), and intraperitoneal (ip) administration. Using this data and set of graphs, determine:(calculate for each variable) (a) k, C0, V, and AUC* for the bolus iv data (b) k, ka, B1, and AUC* for the po data c) k, ka, B1, and AUC* for the ip data (d) relative bioavailability for po vs ip, Fpo/Fip (e)absolute ip bioavailability, Fip (f) absolute po bioavailability, Fpo